BioPharm International, February 2014 - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

BioPharm International, February 2014
Features
Tackling the Challenge of Higher-Order Structure Determination
By Cynthia Challener, PhD
Advances in instrumentation, software, and methodologies provide more information than ever on the higher-order structure of proteins.
Peer-Reviewed Research
Dilution-Free Protein Concentration Measurement by Absorbance at 280 nm for High Protein Concentration Samples
By Lyn Watson , Kannappan Veeraragavan, PhD
Accurate protein concentration results can be obtained using standard spectrophotometers and commercially available short path length absorption cells.
Troubleshooting
Advances in UPLC Techniques and Column Chemistry Aid the Confirmation of Biosimilarity
By Cynthia Challener, PhD
Automated sample handling, advanced glycan analysis and specially designed columns are helping biosimilar manufacturers speed up confirmation of the biosimilarity of their products.
The Disposables Advisor
Cytotoxicity Risks in Single-use Media and Bioreactor Containers
By Jerold Martin
Studies show diminished cell growth properties associated with some biocontainer or bioreactor films.
Perspectives on Outsourcing
Novel Expression Systems Opening CMO Opportunities
By Eric Langer
CMOs may find opportunities in alternative expression services.
European Beat
EMA Collaborates with HTA Assessment Networks
By Sean Milmo
High technology assessments are having an impact on biosimilars development in Europe.
Global Reports
The Affordable Care Act's Impact on Innovation in Biopharma
By Jill E. Sackman, PhD , Rita E. Numerof, PhD , Michael Abrams
The biopharmaceutical industry contemplates product innovation within the changing landscape of healthcare.
From the Editor
Defining Quality Metrics is No Easy Task
By Rita Peters
ISPE and PDA take on the challenge of recommending quality metrics.

ADVERTISEMENT

ADVERTISEMENT

Click here